Holen Sie sich die Stockscreener-App
30.63
1.89%
-0.59
Handel nachbörslich:
30.63
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt TNDM?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$31.22
Offen:
$31.41
24-Stunden-Volumen:
428.24K
Relative Volume:
0.33
Marktkapitalisierung:
$2.01B
Einnahmen:
$796.00M
Nettoeinkommen (Verlust:
$-136.49M
KGV:
-9.483
EPS:
-3.23
Netto-Cashflow:
$-64.24M
1W Leistung:
-0.58%
1M Leistung:
-6.98%
6M Leistung:
-40.81%
1J Leistung:
+54.54%
1-Tages-Spanne:
$30.56
$31.76
1-Wochen-Bereich:
$29.99
$31.76
52-Wochen-Spanne:
$18.45
$53.69
Tandem Diabetes Care Inc Stock (TNDM) Company Profile
Firmenname
Tandem Diabetes Care Inc
Sektor
Branche
Telefon
858-366-6900
Adresse
12400 HIGH BLUFF DRIVE, San Diego, CA
Vergleichen Sie TNDM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TNDM
Tandem Diabetes Care Inc
|
30.63 | 2.01B | 796.00M | -136.49M | -64.24M | -2.09 |
|
ABT
Abbott Laboratories
|
118.77 | 206.00B | 41.22B | 5.77B | 6.49B | 3.29 |
|
SYK
Stryker Corp
|
392.15 | 149.49B | 21.97B | 3.59B | 3.21B | 9.33 |
|
BSX
Boston Scientific Corp
|
90.66 | 133.62B | 15.91B | 1.79B | 1.89B | 1.21 |
|
MDT
Medtronic Plc
|
86.54 | 110.97B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
71.35 | 42.08B | 6.60B | 4.16B | 490.10M | 6.93 |
Tandem Diabetes Care Inc Stock (TNDM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-11-06 | Eingeleitet | Bernstein | Outperform |
| 2024-10-04 | Eingeleitet | Goldman | Neutral |
| 2024-10-02 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2024-08-22 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2024-08-08 | Eingeleitet | Canaccord Genuity | Buy |
| 2024-05-30 | Eingeleitet | Redburn Atlantic | Buy |
| 2024-05-22 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-04-29 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-04-25 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2024-03-26 | Hochstufung | Stifel | Hold → Buy |
| 2023-08-04 | Herabstufung | Citigroup | Buy → Neutral |
| 2023-05-05 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-04-24 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2023-03-29 | Eingeleitet | UBS | Neutral |
| 2023-01-26 | Eingeleitet | Wolfe Research | Peer Perform |
| 2022-11-15 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2022-10-18 | Eingeleitet | Barclays | Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2022-08-09 | Herabstufung | Wells Fargo | Overweight → Underweight |
| 2022-03-02 | Fortgesetzt | BofA Securities | Neutral |
| 2022-01-19 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2021-07-21 | Fortgesetzt | Cowen | Outperform |
| 2021-05-25 | Eingeleitet | Barclays | Underweight |
| 2020-12-15 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2020-08-20 | Eingeleitet | Wells Fargo | Overweight |
| 2020-07-31 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-07-06 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-06-18 | Bestätigt | Raymond James | Outperform |
| 2020-04-24 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2020-03-23 | Herabstufung | Guggenheim | Buy → Neutral |
| 2020-03-05 | Eingeleitet | Citigroup | Neutral |
| 2020-02-06 | Eingeleitet | Raymond James | Outperform |
| 2020-02-04 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2019-10-18 | Eingeleitet | Guggenheim | Buy |
| 2019-10-04 | Hochstufung | UBS | Neutral → Buy |
| 2019-05-17 | Bestätigt | BofA/Merrill | Neutral |
| 2019-05-13 | Eingeleitet | SVB Leerink | Outperform |
| 2019-03-08 | Eingeleitet | BMO Capital Markets | Outperform |
| 2019-03-05 | Bestätigt | BofA/Merrill | Neutral |
| 2019-02-27 | Bestätigt | Lake Street | Buy |
| 2018-11-21 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2018-09-26 | Bestätigt | Dougherty & Company | Buy |
| 2018-09-26 | Bestätigt | Piper Jaffray | Overweight |
Alle ansehen
Tandem Diabetes Care Inc Aktie (TNDM) Neueste Nachrichten
Fred Alger Management LLC Decreases Position in Tandem Diabetes Care, Inc. (NASDAQ:TNDM) - MarketBeat
TNDM (Tandem Diabetes Care) Total Inventories : $152.4 Mil (As of Sep. 2024) - GuruFocus.com
Tandem Diabetes: Recurring Value Erosion, Not Right Point In Cycle To Own (NASDAQ:TNDM) - Seeking Alpha
Tandem Diabetes Care Inc (TNDM) Stock Price Up 3.99% on Nov 27 - GuruFocus.com
FY2024 Earnings Forecast for TNDM Issued By Leerink Partnrs - MarketBeat
46,304 Shares in Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Acquired by Millrace Asset Group Inc. - MarketBeat
Leerink Partnrs Has Negative Outlook of TNDM FY2028 Earnings - MarketBeat
Tandem Diabetes Care, Inc. (TNDM): An Oversold Healthcare Stock to Invest In Now - Insider Monkey
10 Oversold Healthcare Stocks To Invest In - Insider Monkey
Don't Ignore The Insider Selling In Tandem Diabetes Care - Simply Wall St
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Director Kim D. Blickenstaff Sells 10,000 Shares - MarketBeat
Kim D. Blickenstaff Sells 10,000 Shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Stock - MarketBeat
Kim Blickenstaff sells $1.24 million in Tandem Diabetes stock By Investing.com - Investing.com South Africa
Kim Blickenstaff sells $1.24 million in Tandem Diabetes stock - Investing.com
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Shares Acquired by Connor Clark & Lunn Investment Management Ltd. - MarketBeat
Tandem Diabetes Care (STU:TD5A) Debt-to-EBITDA : -7.20 (As of Sep. 2024) - GuruFocus.com
Tandem Diabetes Care Announces Upcoming Conference Presentations - Marketscreener.com
Brown Capital Management LLC Reduces Stock Position in Tandem Diabetes Care, Inc. (NASDAQ:TNDM) - MarketBeat
Jennison Associates LLC Sells 187,623 Shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM) - MarketBeat
Tandem Diabetes Care, Inc. (TNDM) Reports Q3 Loss, Tops Revenue Estimates - MSN
Tandem Diabetes Care (TNDM) Reports Q3 Earnings: What Key Metrics Have to Say - MSN
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Shares Bought by LMR Partners LLP - MarketBeat
Tandem Diabetes Care executive purchases shares worth $12,363 By Investing.com - Investing.com Canada
Tandem Diabetes Care executive purchases shares worth $12,363 - Investing.com
Tandem Diabetes Care Inc (TNDM) Shares Up 5.19% on Nov 19 - GuruFocus.com
Oppenheimer & Co. Inc. Grows Stake in Tandem Diabetes Care, Inc. (NASDAQ:TNDM) - MarketBeat
Automated Insulin Delivery Systems Market Trends, - openPR
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Shares Sold by KBC Group NV - MarketBeat
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Shares Acquired by Victory Capital Management Inc. - MarketBeat
Slammed 27% Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Screens Well Here But There Might Be A Catch - Simply Wall St
Principal Financial Group Inc. Has $15.71 Million Holdings in Tandem Diabetes Care, Inc. (NASDAQ:TNDM) - MarketBeat
(TNDM) Proactive Strategies - Stock Traders Daily
Simplify Asset Management Inc. Acquires New Stake in Tandem Diabetes Care, Inc. (NASDAQ:TNDM) - MarketBeat
Diabetes Devices Drugs Market Overall Study Report 2024-2032 | - openPR
Insulin Infusion Pumps Market Size, Share, Outlook, Industry - openPR
Tandem Diabetes Care's SWOT analysis: insulin pump maker's stock faces growth hurdles - Investing.com
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Lisanti Capital Growth LLC Decreases Stock Holdings in Tandem Diabetes Care, Inc. (NASDAQ:TNDM) - MarketBeat
Leerink Partnrs Has Negative Outlook of TNDM FY2024 Earnings - MarketBeat
Tandem Diabetes Care (NASDAQ:TNDM) Shares Down 9.6% Following Analyst Downgrade - MarketBeat
Tandem Diabetes Care (NASDAQ:TNDM) Issues Quarterly Earnings Results - MarketBeat
Oversold Conditions For Tandem Diabetes Care (TNDM) - Nasdaq
Barclays Forecasts Strong Price Appreciation for Tandem Diabetes Care (NASDAQ:TNDM) Stock - MarketBeat
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Q3 2024 Earnings Call Transcript - Insider Monkey
TNDM Q3 Earnings Beat, '24 Sales View Up, Stock Falls in Aftermarket - Yahoo Finance
Tandem Diabetes price target lowered to $37 from $39 at Baird - Yahoo Finance
Tandem Diabetes Care Third Quarter 2024 Earnings: Beats Expectations - Simply Wall St
Analyst Estimates: Here's What Brokers Think Of Tandem Diabetes Care, Inc. (NASDAQ:TNDM) After Its Third-Quarter Report - Yahoo Finance
Tandem Diabetes Care (NASDAQ:TNDM) Price Target Lowered to $56.00 at Canaccord Genuity Group - MarketBeat
Robert W. Baird Cuts Tandem Diabetes Care (NASDAQ:TNDM) Price Target to $37.00 - MarketBeat
Tandem Diabetes Care Inc (TNDM) Q3 2024 Earnings Call Highlights: Record Sales and Strategic Growth Initiatives - GuruFocus.com
Finanzdaten der Tandem Diabetes Care Inc-Aktie (TNDM)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.73%
0.14%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):